Status:
UNKNOWN
Cervical Morphological Changes on Pregnancy Outcome
Lead Sponsor:
The Second Affiliated Hospital of Chongqing Medical University
Conditions:
Pregnancy Outcome
Eligibility:
FEMALE
21-45 years
Brief Summary
This study aims to assess how the proportion of the cervical volume/length removed during treatment for cervical intraepithelial neoplasia (CIN) varies and whether this correlates to the pregnancy dur...
Detailed Description
The high peak age of the Cervical intraepithelial neoplasia (CIN)patients was from 25 to 35 years old, which is the best women of childbearing age, Standard treatment for CIN is called Loop electrosur...
Eligibility Criteria
Inclusion
- Having fertility requirements,antecedent biopsy read as
- cervical intraepithelial neoplasia (CIN) grade 2 or 3 or microinvasive cancer
- adenocarcinoma in situ
- persistent CIN 1
- antecedent pap read as
- high grade squamous intraepithelial lesion
- atypical glandular cells
- persistent low grade squamous intraepithelial lesion
Exclusion
- anatomy unsuitable for safe office loop excision based on operator judgement
- inability to tolerate procedure under local anesthesia
- pregnancy
- age less than 21 years
- refusal of consent
- prisoner
- mental incapacity
- anticoagulant or antiplatelet therapy, or known bleeding diathesis
- use of analgesics other than over the counter medications(OTC meds include NSAIDS or Tylenol) within 7 days of scheduled LEEP.
Key Trial Info
Start Date :
September 15 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03242746
Start Date
September 15 2017
End Date
September 1 2021
Last Update
June 27 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
2ndChongqingMU
Yuzhong, Chongqing Municipality, China, 023